Comparison of Oral versus Intravenous Ramosetron in Prevention of Acute Cisplatin-Induced Emesis: A Randomized Controlled Trial

• Main Authors: Tantipalakorn C., Thienthong H., Suprasert P., Eamtang S., Pautad N., Srisomboon J., Pantusart A., Saereesongkhun C., Sutthichat A.
• Format: Article
• Language: English
• Published: 2014
• Online Access: http://www.scopus.com/inward/record.url?eid=2-s2.0-1842761441&partnerID=40&md5=b9f7e6fc995d0a4c2056ce5f1a70e25e; http://www.ncbi.nlm.nih.gov/pubmed/15061293; http://cmuir.cmu.ac.th/handle/6653943832/1722
• Institution: Chiang Mai University

Objective: To compare the antiemetic efficacy of a single oral versus intravenous (IV) ramosetron, a new class of selective 5-HT3 receptor antagonists, in gynecologic cancer patients receiving high-dose cisplatin. Method: Between February 2003 and July 2003, 109 patients with gynecologic cancer sche...